Contents

Current Drug Targets, Volume 12 - Number 10

Editorial [Hot Topic: Ulcerative Colitis: A Cinderella Story (Guest Editor: Silvio Danese)]

, 12(10): 1372

Silvio Danese


DOI: 10.2174/138945011796818207




Ulcerative Colitis: Pathogenesis

, 12(10): 1373 - 1382

Walter Fries and Salvatore Comunale


DOI: 10.2174/138945011796818261




Genetics and Ulcerative Colitis: What are the Clinical Implications?

, 12(10): 1383 - 1389

Anna Latiano and Vito Annese


DOI: 10.2174/138945011796818171




Natural History of Ulcerative Colitis: Current Knowledge

, 12(10): 1390 - 1395

Lajos Sandor Kiss and Peter Laszlo Lakatos


DOI: 10.2174/138945011796818117




Is 5-ASA Still the Treatment of Choice for Ulcerative Colitis?

, 12(10): 1396 - 1405

Mario Cottone, Sara Renna, Irene Modesto and Ambrogio Orlando


DOI: 10.2174/138945011796818126




Thiopurine Immunomodulators in Ulcerative Colitis: Moving Forward with Current Evidence

, 12(10): 1406 - 1412

Richard J. La Nauze and Miles P. Sparrow


DOI: 10.2174/138945011796818180




Methotrexate: A Drug of the Future in Ulcerative Colitis?

, 12(10): 1413 - 1416

Franck Carbonnel


DOI: 10.2174/138945011796818252




Mucosal Healing in Ulcerative Colitis: Where do we Stand?

, 12(10): 1417 - 1423

Gionata Fiorino, Monica Cesarini, Amedeo Indriolo and Alberto Malesci


DOI: 10.2174/138945011796818216




How to Manage the Risk of Colorectal Cancer in Ulcerative Colitis

, 12(10): 1424 - 1432

Raja Affendi Raja Ali and Laurence John Egan


DOI: 10.2174/138945011796818270




Biological Therapy for Ulcerative Colitis: What is after Anti-TNF

, 12(10): 1433 - 1439

Gionata Fiorino, Monica Cesarini and Silvio Danese


DOI: 10.2174/138945011796818225




Does Anti-TNF Therapy Reduce the Requirement for Surgery in Ulcerative Colitis? A Systematic Review

, 12(10): 1440 - 1447

Jerome Filippi, Patrick B. Allen, Xavier Hebuterne and Laurent Peyrin-Biroulet


DOI: 10.2174/138945011796818153




Acute Severe Colitis: Infliximab and/or Cyclosporine?

, 12(10): 1448 - 1453

Mauro Fabro, Hajnalka Szabo, Giovanni Terrosu, Claudio Avellini, Maria Tabuso, Gionata Fiorino and Dario Sorrentino


DOI: 10.2174/138945011796818234




How to Manage Pouchitis in Ulcerative Colitis?

, 12(10): 1454 - 1461

F. Magro, S. Lopes, S. Rodrigues and I. Azevedo


DOI: 10.2174/138945011796818144




Surgical Approach to Ulcerative Colitis: When is the Best Timing after Medical Treatment?

, 12(10): 1462 - 1466

Antonino Spinelli, Gianluca M. Sampietro, Piero Bazzi, Matteo Sacchi and Marco Montorsi


DOI: 10.2174/138945011796818199




Lessons to Learn from Crohn's Disease Clinical Trials: Implications for Ulcerative Colitis

, 12(10): 1467 - 1477

Aranzazu Jauregui-Amezaga, Elena Ricart and Julian Panes


DOI: 10.2174/138945011796818162




Evaluation of Dendrimer Safety and Efficacy through Cell Line Studies

, 12(10): 1478 - 1497

Prashant Kesharwani, Virendra Gajbhiye, Rakesh K. Tekade and Narendra K. Jain


DOI: 10.2174/138945011796818135




Thiazolidinediones and Type 2 Diabetes: From Cellular Targets to Cardiovascular Benefit

, 12(10): 1498 - 1512

Georgios S. Papaetis, Dora Orphanidou and Themistoklis N. Panagiotou


DOI: 10.2174/138945011796818243




Webmaster Contact: info@benthamscience.org
Copyright © 2018 Bentham Science